Does Strong Q1 Results And CFO Transition Change The Bull Case For Viatris (VTRS)?
Viatris Inc VTRS
$16.48
▼ -4.52%
($-0.78)
Index member:
S&P 500
Open
$17.17
Prev Close
$17.26
Day Range
$16.40 – $17.17
52W Range
$8.19 – $17.53
Market Cap
$18.07B
Beta
0.91
Div Yield
3.09%
EPS (TTM)
$-0.26
📋 Company Profile
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1973-02-01 |
| Shares Out. | 1,164,420,000 |
| Website | viatris.com/en ↗ |
| Phone | 13026587581 |
Viatris Inc is a publicly traded company under the ticker symbol VTRS on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
18 analysts (2026-05-01)
📰 Latest News for VTRS
3 Unprofitable Stocks That Fall Short
Novo Nordisk: Why A P/E Of 13 Is A Value Trap, Not A Bargain
Viatris Inc. (VTRS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Transcript : Viatris Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 08
Viatris: From Cost Story To Pipeline-Driven Re-Rating (Rating Upgrade)
VTRS Q1 Deep Dive: China Strength, R&D Pipeline, and Execution Drive Outperformance
Viatris: The Cigar Butt Got Smoked, But I'm Holding The Rating